Brief: Pacbio Announces Onso, The Highly Accurate Short-Read Sequencing Platform
26/10/2022 03:37
Oct 25 (Reuters) - Pacific Biosciences of California Inc
PACB.O :
* PACBIO ANNOUNCES ONSO, THE HIGHLY ACCURATE SHORT-READ
SEQUENCING
PLATFORM
* PACIFIC BIOSCIENCES OF CALIFORNIA INC - EXPECTS TO BEGIN
TAKING
ORDERS FOR ONSO IN Q1 2023 AND EXPECTS TO BEGIN SHIPMENTS OF
SYSTEM IN H1 2023
* PACIFIC BIOSCIENCES - TO DELIVER 500 MILLION READS PER RUN
&
OFFER 200, 300 CYCLE KITS ENABLING PAIRED- & SINGLE-END READS,
AT LIST PRICE OF $259,000/SYSTEM
Source text for Eikon: ID:nPn2MC4HXa
Further company coverage: PACB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacific Biosciences of California
See all newsBrief: Pacbio And Verily Health Announce Multi-Year Strategic Collaboration
Pacific Biosciences of California, Inc. reports results for the quarter ended June 30 - Earnings Summary
Pacific Biosciences Q2 adj. loss bigger than estimates on margin pressure
Brief: Pacific Biosciences of California Q2 EPS USD -0.14
Pacific Biosciences of California Inc expected to post a loss of 13 cents a share - Earnings Preview